Rita Nahta, Ph.D.
Affiliations: | 2000 | Duke University, Durham, NC |
Area:
Molecular BiologyGoogle:
"Rita Nahta"Parents
Sign in to add mentor| Jeffrey R. Marks | grad student | 2000 | Duke | |
| (P53 and the G2 checkpoint in human breast cancer.) | ||||
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Peake BF, Eze SM, Yang L, et al. (2020) Correction: Growth differentiation factor 15 mediates epithelial mesenchymal transition and invasion of breast cancers through IGF-1R-FoxM1 signaling. Oncotarget. 11: 4074-4075 |
| Zhao J, Meisel J, Guo Y, et al. (2020) Evaluation of PD-L1, tumor-infiltrating lymphocytes, and CD8+ and FOXP3+ immune cells in HER2-positive breast cancer treated with neoadjuvant therapies. Breast Cancer Research and Treatment |
| Meisel JL, Zhao J, Suo A, et al. (2019) Clinicopathologic Factors Associated With Response to Neoadjuvant Anti-HER2-Directed Chemotherapy in HER2-Positive Breast Cancer. Clinical Breast Cancer |
| O'Regan RM, Nahta R. (2018) Targeting Forkhead Box M1 Transcription Factor in Breast Cancer. Biochemical Pharmacology |
| Paplomata E, Nahta R. (2018) ABP 980: Promising Trastuzumab Biosimilar for HER2-Positive Breast Cancer. Expert Opinion On Biological Therapy |
| Akamandisa MP, Nie K, Wen J, et al. (2018) Abstract B05: Mechanisms of PPM1D-mediated tumorigenesis in diffuse intrinsic pontine glioma (DIPG) Cancer Research. 78 |
| Peake BF, Eze SM, Yang L, et al. (2017) Growth differentiation factor 15 mediates epithelial mesenchymal transition and invasion of breast cancers through IGF-1R-FoxM1 signaling. Oncotarget. 8: 94393-94406 |
| Qi L, Zhang B, Zhang S, et al. (2017) ERRF sensitizes ERBB2-positive breast cancer cells to lapatinib treatment likely by attenuating MCL1 and ERBB2 expression. Oncotarget |
| Wen J, Lee J, Malhotra A, et al. (2016) WIP1 modulates responsiveness to Sonic Hedgehog signaling in neuronal precursor cells and medulloblastoma. Oncogene |
| Block KI, Gyllenhaal C, Lowe L, et al. (2015) Designing a broad-spectrum integrative approach for cancer prevention and treatment. Seminars in Cancer Biology. 35: S276-304 |